TAMIR WARDANY

Dental Providers|Dentist|General Practice SAN FRANCISCO, CA NPI 1124199880

General Payments — all program years on this page

$48,147.57

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 63
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $5,033.90 across 13 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
GEISTLICH PHARMA, NORTH AMERICA, INC. $4,033.9012
Envista Holdings Corporation $1,000.001

By program year

Program yearAmountRecords
2018 $2,576.494
2019 $3,214.1010
2020 $6,329.257
2021 $17,913.4314
2022 $11,879.348
2023 $1,201.067
2024 $5,033.9013

Records — PY2024 (13)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1121370327 Geistlich Pharma, North America, Inc. $7.55 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121370329 Geistlich Pharma, North America, Inc. $21.27 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121370331 Geistlich Pharma, North America, Inc. $5.55 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121370333 Geistlich Pharma, North America, Inc. $8.70 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121370335 Geistlich Pharma, North America, Inc. $23.50 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121370337 Geistlich Pharma, North America, Inc. $8.39 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121370339 Geistlich Pharma, North America, Inc. $6.83 03/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121370341 Geistlich Pharma, North America, Inc. $117.36 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121370343 Geistlich Pharma, North America, Inc. $60.00 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121370345 Geistlich Pharma, North America, Inc. $16.17 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1121374209 Geistlich Pharma, North America, Inc. $2,616.78 03/27/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1121374211 Geistlich Pharma, North America, Inc. $1,141.80 08/20/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1143731521 Envista Holdings Corporation $1,000.00 10/17/2024 Compensation for serving as faculty or as a speaker for a medical education program Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.